Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

First-of-its-kind data shows Novartis’ iscalimab extends survival of transplanted kidneys

June 6, 2019 Research and Development Novartis, iscalimab, kidney transplant, pharma, transplant

In a first-of-its-kind reveal, Novartis has presented histology data for iscalimab (CFZ533) at the American Transplant Congress (ATC) which indicates …
News
entrance_takeda_i020_v1

Takeda’s Ninlaro fails to meet one of two primary endpoints in Phase 3 trial

June 6, 2019 Research and Development TOURMALINE-AL1, Takeda, pharma, phase 3, trial Ninlaro

Takeda has decided to discontinue its Phase 3 study of Ninlaro (ixazomib) after the drug in combination with dexamethasone, failed …
News

Pfizer supressed research suggesting arthritis drug Enbrel reduced risk of Alzheimer’s by 64%

June 6, 2019 Research and Development Alzheimer's, Drug therapy, Pfizer, dementia, pharma

Pfizer supressed data suggesting that their drug Enbrel reduced the risk of patients developing Alzheimer’s disease by 64%. In 2015, …
News
astrazeneca-sign

AstraZeneca’s Calquence shows strength in most common adult leukaemia

June 6, 2019 Research and Development AstraZeneca, Calquence, chronic lymphocytic leukaemia, pharma

AstraZeneca has unveiled new Phase 3 data for Calquence (acalabrutinib) in treatment-naïve chronic lymphocytic leukaemia, showing that the drug met …
News
merckincweb2

FDA approves new indication for MSD’s Zerbaxa

June 5, 2019 Research and Development Merck, Zerbaxa, bacterial infection, pharma

The FDA has approved US firm Merck’s Zerbaxa (ceftolozane and tazobactam) for adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial …
News
abbvie_0

AbbVie’s Venclyxto combo outclasses chemo in treatment-naive chronic lymphocytic leukaemia

June 5, 2019 Research and Development ASCO 2019, AbbVie, Venclyxto, pharma

AbbVie was one of many companies to present new data at this year’s American Society of Clinical Oncology (ASCO) Annual …
News
condom-3197506_960_720

Cases of sexually transmitted infections on the rise in England, data shows

June 5, 2019 Research and Development HIV, STDs, STIs, pharma PrEP, public health

Cases of sexually transmitted infections (STIs) are on the rise, according to new data from Public Health England. There were …
News
vertex-headquarters

Parents of children with cystic fibrosis start Orkambi buyers club

June 5, 2019 Research and Development NHS, Orkambi, Vertex, cystic fibrosis

Parents of children with cystic fibrosis have started an Orkambi buyers’ club to import generic versions of Vertex’s drug from …
News
lilly_entrance_web

Eli Lilly’s Emgality approved in the US for episodic cluster headache

June 5, 2019 Research and Development, Sales and Marketing Eli Lilly, Emgality, episodic cluster headache, migraine, pharma

Eli Lilly’s Emgality (galcanezumab-gnlm) self-administered injection solution has secured approval in the US for the treatment of episodic cluster headache, …
News
dr_zhang

NeoImmuneTech names experienced pharma exec Dr Samuel Zhang as company’s new Chief Business Officer

June 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Maryland-based biotech NeoImmuneTech has named Dr Samuel Zhang as the company’s new Chief Business Officer (CBO). Dr Zhang brings to …
Appointment
scott_gottlieb

Former FDA Commissioner returns to venture capital firm

June 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, appointment, pharma

Dr Scott Gottlieb, former Commissioner for the FDA, has returned to his venture capital background with the announcement that he …
Appointment
shutterstock_159488225

Darzalex combo makes strong Phase 3 showing in multiple myeloma

June 4, 2019 Manufacturing and Production, Research and Development ASCO 2019, Cancer, Janssen, darzalex, multiple myeloma, pharma

Janssen joined its contemporaries at the 55th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago in the release …
News
amgen_flag

Amgen’s novel KRAS inhibitor monotherapy shows promise at Phase 1 in advanced solid tumours

June 4, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Cancer, KRAS

Amgen has unveiled the first clinical data for its investigational KRAS inhibitor AMG 510, the first such therapy to reach …
News

Working Life: Monika Pocinkova, Vice President, HR Speciality Care, Ipsen UK & Ireland

June 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, pharma

Ipsen’s Vice President of HR Speciality Care discusses the path she has taken throughout her career, the cultural differences she …
Feature
janssen_latest_logo_on_sign_closer

Janssen’s Erleada combo smashes endpoints in advanced hormone-sensitive prostate cancer

June 3, 2019 Research and Development, Sales and Marketing ASCO 2019, Cancer, Erleada, Janssen, prostate cancer

Janssen joined the showing at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago to present new …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025